1 |
Korea Centers for Disease Control and Prevention. National guideline for tuberculosis control, 2018 [cited 2019 Jul 20]. Available from: http://www.cdc.go.kr/board.es?mid=a20507020000&bid=0019&act=view&list_no=138005 (Korean).
|
2 |
Chawla H, Lobato MN, Sosa LE, ZuWallack R. Predictors for a positive QuantiFERON-TB-Gold test in BCG-vaccinated adults with a positive tuberculin skin test. J Infect Public Health 2012;5(6):369-373.
DOI
|
3 |
Kitai I, Morris SK, Kordy F, Lam R. Diagnosis and management of pediatric tuberculosis in Canada. CMAJ 2017;189(1):E11-E16.
DOI
|
4 |
Hartman-Adams H, Clark K, Juckett G. Update on latent tuberculosis infection. Am Fam Physician 2014;89(11):889-896.
|
5 |
Korea Centers for Disease Control and Prevention. A to Z of latent tuberculosis infection [cited 2019 Jul 20]. Available from: http://www.cdc.go.kr/board.es?mid=a20501000000&bid=0015&act=view&list_no=143180 (Korean).
|
6 |
Gu H. News: students were tested after teachers. JIBS; 2018 Dec 28 [cited 2019 Feb 20]. Available from: http://www.jibs.co.kr/news/replay/viewNewsReplayDetail/2018122821491458590?feed=na (Korean).
|
7 |
Starke JR; Committee On Infectious Diseases. Interferon- release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics 2014;134(6):e1763-e1773.
DOI
|
8 |
Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon- release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis. Chest 2012;142(1):63-75.
DOI
|
9 |
Moon HW, Hur M. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review. Ann Clin Lab Sci 2013;43(2):221-229.
|
10 |
Soysal A, Turel O, Toprak D, Bakir M. Comparison of positive tuberculin skin test with an interferon-gamma-based assay in unexposed children. Jpn J Infect Dis 2008;61(3):192-195.
|